Definium Therapeutics Inc. Common Shares vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF trades at $39.54 (market cap $28.90M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 163× YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF for 60 Days on average.
| DFTX | QDTY | |
|---|---|---|
Market Cap | $4.71B | $28.90M |
Volume | 1,966,636 | 22,657 |
Sector | Health | Income / Options Overlay |
52-Week High | $48.45 | $46.71 |
52-Week Low | $10.68 | $36.57 |
Typical Hold Time | 0 Days | 60 Days |
Enterprise Value | $3.67B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →QDTY is an actively managed ETF that employs a synthetic covered call strategy on the Nasdaq-100 Index using zero-days-to-expiration (0DTE) options. It aims to generate high weekly income by selling daily call options, providing limited participation in the index's upside while remaining fully exposed to its downside risk.
Read more on QDTY →